Showing stories 1 - 2 of about 2
Tekmira Pharmaceuticals Corp's "Buy" Rating Reaffirmed at Maxim Group (TKMR)
Tekmira Pharmaceuticals Corp logo Tekmira Pharmaceuticals Corp (NASDAQ: TKMR)'s stock had its �buy� rating reaffirmed by research analysts at Maxim Group in a report released on Tuesday, TheFlyOnTheWall.
Stock Analysts' Ratings Reiterations for June, 18th (AEO, AET, AGEN, AGU, APC ...
Tenneco (NYSE: TEN) had its buy rating reiterated by analysts at Deutsche Bank. Deutsche Bank currently has a $51.00 price target on the stock.
Related articles »